BioSpace

Compliance concerns hinder rollout of AI in drug manufacturing: Survey

While AI is taking off in biopharma for administrative tasks and drug discovery efforts, more than 90% of drugmakers have yet to commit to scaling AI use in regulated biopharma manufacturing, according to CRB’s new Horizons: Life Sciences report.

By BioSpace

1 min read
Compliance concerns hinder rollout of AI in drug manufacturing: Survey
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights